Oobli has secured US FDA Generally Recognized as Safe (GRAS) status for its sweet protein Monellin, expanding its platform of sugar alternatives for F&B applications. “Oobli is changing the future of sweetness through the use of sweet proteins as a replacement for traditional cane sugar and other alternative sweeteners like aspartame, sucralose, stevia and erythritol,” says Jason Ryder, Oobli founder and CTO, and adjunct professor of Chemical and Biomolecular Engineering at the University of California Berkeley.
